Literature DB >> 20356927

Evidence that the tumor-suppressor protein BRCA2 does not regulate cytokinesis in human cells.

Sergey Lekomtsev1, Julien Guizetti, Andrei Pozniakovsky, Daniel W Gerlich, Mark Petronczki.   

Abstract

Germline mutations in the tumor-suppressor gene BRCA2 predispose to breast and ovarian cancer. BRCA2 plays a well-established role in maintaining genome stability by regulating homologous recombination. BRCA2 has more recently been implicated in cytokinesis, the final step of cell division, but the molecular basis for this remains unknown. We have used time-lapse microscopy, recently developed cytokinesis assays and BAC recombineering (bacterial artificial chromosome recombinogenic engineering) to investigate the function and localization of BRCA2 during cell division. Our analysis suggests that BRCA2 does not regulate cytokinesis in human cells. Thus, cytokinesis defects are unlikely to contribute to chromosomal instability and tumorigenesis in BRCA2-related cancers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20356927     DOI: 10.1242/jcs.068015

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  18 in total

1.  BRCA2 localization to the midbody by filamin A regulates cep55 signaling and completion of cytokinesis.

Authors:  Gourish Mondal; Matthew Rowley; Lucia Guidugli; Jianmin Wu; Vernon S Pankratz; Fergus J Couch
Journal:  Dev Cell       Date:  2012-07-05       Impact factor: 12.270

2.  brca2 in zebrafish ovarian development, spermatogenesis, and tumorigenesis.

Authors:  Heather R Shive; Robert R West; Lisa J Embree; Mizuki Azuma; Raman Sood; Paul Liu; Dennis D Hickstein
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

3.  Genome annotation by shotgun inactivation of a native gene in hemizygous cells: application to BRCA2 with implication of hypomorphic variants.

Authors:  Soma Ghosh; Anil K Bhunia; Bogdan C Paun; Samuel F Gilbert; Urmil Dhru; Kalpesh Patel; Scott E Kern
Journal:  Hum Mutat       Date:  2015-02       Impact factor: 4.878

4.  BRCA2 minor transcript lacking exons 4-7 supports viability in mice and may account for survival of humans with a pathogenic biallelic mutation.

Authors:  Eswary Thirthagiri; Kimberly D Klarmann; Anil K Shukla; Eileen Southon; Kajal Biswas; Betty K Martin; Susan Lynn North; Valentin Magidson; Sandra Burkett; Diana C Haines; Kathleen Noer; Roberta Matthai; Lino Tessarollo; Jadranka Loncarek; Jonathan R Keller; Shyam K Sharan
Journal:  Hum Mol Genet       Date:  2016-02-26       Impact factor: 6.150

5.  The breast cancer susceptibility gene BRCA2 is required for the maintenance of telomere homeostasis.

Authors:  Jaewon Min; Eun Shik Choi; Kwangwoo Hwang; Jimi Kim; Srihari Sampath; Ashok R Venkitaraman; Hyunsook Lee
Journal:  J Biol Chem       Date:  2011-12-20       Impact factor: 5.157

6.  Integrins promote cytokinesis through the RSK signaling axis.

Authors:  Shomita S Mathew; Bethsaida Nieves; Sharon Sequeira; Savitha Sambandamoorthy; Kevin Pumiglia; Melinda Larsen; Susan E Laflamme
Journal:  J Cell Sci       Date:  2013-11-27       Impact factor: 5.285

Review 7.  Beyond cytokinesis: the emerging roles of CEP55 in tumorigenesis.

Authors:  J Jeffery; D Sinha; S Srihari; M Kalimutho; K K Khanna
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

8.  RAS promotes tumorigenesis through genomic instability induced by imbalanced expression of Aurora-A and BRCA2 in midbody during cytokinesis.

Authors:  Gong Yang; Imelda Mercado-Uribe; Asha S Multani; Subrata Sen; Ie-Ming Shih; Kwong-Kwok Wong; David M Gershenson; Jinsong Liu
Journal:  Int J Cancer       Date:  2013-02-12       Impact factor: 7.396

Review 9.  A comprehensive analysis of BRCA2 gene: focus on mechanistic aspects of its functions, spectrum of deleterious mutations, and therapeutic strategies targeting BRCA2-deficient tumors.

Authors:  Anjali Shailani; Raman Preet Kaur; Anjana Munshi
Journal:  Med Oncol       Date:  2018-01-31       Impact factor: 3.064

Review 10.  Molding BRCA2 function through its interacting partners.

Authors:  Juan S Martinez; Céline Baldeyron; Aura Carreira
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.